Jeffrey M Nugent - Net Worth and Insider Trading

Jeffrey M Nugent Net Worth

The estimated net worth of Jeffrey M Nugent is at least $1,521 dollars as of 2024-04-24. Jeffrey M Nugent is the Chairman of the Board and CEO of Sientra Inc and owns about 20,983 shares of Sientra Inc (SIENQ) stock worth over $1,521. Details can be seen in Jeffrey M Nugent's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey M Nugent has not made any transactions after 2020-02-20 and currently still holds the listed stock(s).

Transaction Summary of Jeffrey M Nugent

Jeffrey M Nugent Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey M Nugent owns 3 companies in total, including Sientra Inc (SIENQ) , Evofem Biosciences Inc (EVFM) , and Biolase Inc (BIOL) .

Click here to see the complete history of Jeffrey M Nugent’s form 4 insider trades.

Insider Ownership Summary of Jeffrey M Nugent

Ticker	Comapny	Transaction Date	Type of Owner
SIENQ	Sientra Inc	2020-02-20	director
EVFM	Evofem Biosciences Inc	2015-09-23	director
BIOL	Biolase Inc	2014-06-16	director & Acting Chief Executive Officer

Jeffrey M Nugent Latest Holdings Summary

Jeffrey M Nugent currently owns a total of 1 stock. Jeffrey M Nugent owns 20,983 shares of Sientra Inc (SIENQ) as of February 20, 2020, with a value of $1,521.

Latest Holdings of Jeffrey M Nugent

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SIENQ	Sientra Inc	2020-02-20	20,983	0.07	1,521

Holding Weightings of Jeffrey M Nugent

Jeffrey M Nugent Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey M Nugent has made a total of 1 transactions in Sientra Inc (SIENQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sientra Inc is the sale of 13,358 shares on February 20, 2020, which brought Jeffrey M Nugent around $792,106.

Insider Trading History of Jeffrey M Nugent

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey M Nugent Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey M Nugent's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey M Nugent is 30.76%. GuruFocus also compares Jeffrey M Nugent's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey M Nugent within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey M Nugent's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey M Nugent

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	23.49	30.76	27.28	-49.17	-63.43	-23.92
Relative Return to S&P 500(%)	19.83	23.81	21.99	-57.08	-67.25	-40.47

Jeffrey M Nugent Ownership Network

Ownership Network List of Jeffrey M Nugent

No Data

Ownership Network Relation of Jeffrey M Nugent

Jeffrey M Nugent Owned Company Details

What does Sientra Inc do?

Who are the key executives at Sientra Inc?

Jeffrey M Nugent is the director of Sientra Inc. Other key executives at Sientra Inc include director & President and CEO Ronald Menezes , General Counsel and VP Oliver Christian Bennett , and Chief Financial Officer Andrew C Schmidt .

Sientra Inc (SIENQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sientra Inc (SIENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sientra Inc (SIENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sientra Inc (SIENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sientra Inc Insider Transactions

No Available Data

What does Evofem Biosciences Inc do?

Who are the key executives at Evofem Biosciences Inc?

Jeffrey M Nugent is the director of Evofem Biosciences Inc. Other key executives at Evofem Biosciences Inc include Chief Financial Officer Yan Zhang , director & 10 percent owner Kim P. Kamdar , and Chief Commercial Officer Atkinson Katherine Cocca .

Evofem Biosciences Inc (EVFM) Insider Trades Summary

Over the past 18 months, Jeffrey M Nugent made no insider transaction in Evofem Biosciences Inc (EVFM). Other recent insider transactions involving Evofem Biosciences Inc (EVFM) include a net sale of 104 shares made by Yan Zhang , and a net sale of 10 shares made by Kim P. Kamdar .

In summary, during the past 3 months, insiders sold 0 shares of Evofem Biosciences Inc (EVFM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114 shares of Evofem Biosciences Inc (EVFM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114 shares.

Evofem Biosciences Inc (EVFM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Evofem Biosciences Inc Insider Transactions

No Available Data

What does Biolase Inc do?

Who are the key executives at Biolase Inc?

Jeffrey M Nugent is the director & Acting Chief Executive Officer of Biolase Inc. Other key executives at Biolase Inc include 10 percent owner Goldman Sachs Group Inc , 10 percent owner Goldman Sachs & Co. Llc , and Chief Financial Officer Jennifer Bright .

Biolase Inc (BIOL) Insider Trades Summary

Over the past 18 months, Jeffrey M Nugent made no insider transaction in Biolase Inc (BIOL). Other recent insider transactions involving Biolase Inc (BIOL) include a net sale of 3,537 shares made by Lord Jonathan T Md ,

In summary, during the past 3 months, insiders sold 0 shares of Biolase Inc (BIOL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35 shares of Biolase Inc (BIOL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35 shares.

Biolase Inc (BIOL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biolase Inc Insider Transactions

No Available Data

Jeffrey M Nugent Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey M Nugent. You might contact Jeffrey M Nugent via mailing address: 1875 South Grant Street, Suite 110, San Mateo Ca 94402.

Discussions on Jeffrey M Nugent

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.